AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Sep 5, 2012
30016_dirs_2012-09-05_e562abd8-a82a-4e77-9dea-c9e2b25ff612.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-09-01
Reporting Person: Meyaard Daniel V (Corporate Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-01 | Common Stock | M | 810 | — | Acquired | 4020 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-01 | Restricted Stock Unit | $ | M | 810 | Disposed | Common Stock (810) | Direct |
Footnotes
F1: Includes 79 shares and 49 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/30/2012 and 06/30/2012, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (09/01/2010) of the date of grant.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13